Myomo, Inc.
myomo.com ↗In their words
“Ur target client, but also highly scalable, which we expect will allow us to grow our footprint aggressively across the states where we currently operate as well as opening new states. Over the past few years, we have demonstrated our value by driving above 5-star medication adherence scores for our cohort of patients, while achieving an amazing Net Promoter Score of 90.”
NPS disclosures (1)
…ur target client, but also highly scalable, which we expect will allow us to grow our footprint aggressively across the states where we currently operate as well as opening new states. Over the past few years, we have demonstrated our value by driving above 5-star medication adherence scores for our cohort of patients, while achieving an amazing Net Promoter Score of 90.
Retention disclosures (0)
No retention figures yet.
Lighthouse companies in Pharma, medtech & health distribution
About these figures
Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.
NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.